User contributions for Alara E. Dagsali
Jump to navigation
Jump to search
15 February 2024
- 01:3801:38, 15 February 2024 diff hist +2 Coronary heart disease in Diabetics No edit summary
- 01:3301:33, 15 February 2024 diff hist 0 Coronary heart disease in Diabetics No edit summary
- 01:3201:32, 15 February 2024 diff hist −4 Coronary heart disease in Diabetics No edit summary
- 01:1601:16, 15 February 2024 diff hist +1 Coronary heart disease in Diabetics No edit summary
- 01:1401:14, 15 February 2024 diff hist +3,056 Coronary heart disease in Diabetics No edit summary
- 01:0701:07, 15 February 2024 diff hist −45 Coronary heart disease in Diabetics No edit summary
- 01:0401:04, 15 February 2024 diff hist +2,663 Coronary heart disease in Diabetics No edit summary
- 00:1700:17, 15 February 2024 diff hist +6,524 Coronary heart disease in Diabetics No edit summary
- 00:0500:05, 15 February 2024 diff hist 0 Coronary heart disease in Diabetics →Recommendations for nutrition in patients with type 2 diabetes with or without cardiovascular disease (DO NOT EDIT)== Tag: Visual edit
- 00:0400:04, 15 February 2024 diff hist +1,869 Coronary heart disease in Diabetics No edit summary Tag: Visual edit: Switched
31 January 2024
- 20:3020:30, 31 January 2024 diff hist +28,883 N Adagrasib Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E. Dagsali |genericName=adagrasib |aOrAn=an |indicationType=treatment |indication=KRAZATI is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test [see DOSAGE AND ADMINISTRATION (2.1)], who have received at least one prior systemic therapy. This indication is approved under accelerated approval based on ob..."
21 December 2023
- 08:4608:46, 21 December 2023 diff hist +4,642 Coronary heart disease in Diabetics No edit summary
- 07:3407:34, 21 December 2023 diff hist +2,774 Coronary heart disease in Diabetics No edit summary
- 07:2007:20, 21 December 2023 diff hist +1 Coronary heart disease in Diabetics /* Recommendations for assessing cardiovascular risk in patients with type 2 diabetes(DO NOT EDIT){{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/el...
- 07:2007:20, 21 December 2023 diff hist +1 Coronary heart disease in Diabetics /* Recommendations for diagnosing diabetes(DO NOT EDIT){{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/c...
- 07:1907:19, 21 December 2023 diff hist +40 Coronary heart disease in Diabetics /* 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.f...
- 07:1807:18, 21 December 2023 diff hist +503 Coronary heart disease in Diabetics /* Recommendations for assessing cardiovascular risk in patients with type 2 diabetes{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfr...
- 07:1607:16, 21 December 2023 diff hist +1,572 Coronary heart disease in Diabetics /* Recommendations for assessing cardiovascular risk in patients with type 2 diabetes{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfr...
- 07:1207:12, 21 December 2023 diff hist +2,107 Coronary heart disease in Diabetics /* 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.f...
- 07:0207:02, 21 December 2023 diff hist +200 Coronary heart disease in Diabetics No edit summary